Pulished Date October, 2018
ID: 6176
Share on
Share on

Rubella Vaccine Market Segmented By End User, And Region -Global Growth, Trends, And Forecast To 2024

Pulished: October, 2018
ID: 6176
Pages: 175

Rubella Vaccine Market Segmented By End-User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018 To 2023)

Global Rubella Vaccine (Human Diploid Cell) market is anticipated to grow at XX % CAGR from 2018 to 2023 and it is estimated that the global market was valued at USD XX billion in 2018 and is expected to reach USD XX billion by 2023.

Rubella is an acute, viral, and contagious infection, which has a mild effect on children and is caused by the transmission of airborne droplets of infected people through sneezing or coughing. However, pregnant women suffering from rubella have to face severe consequences, as the viral infection results in death or congenital defects known as congenital rubella syndrome (CRS). Rubella vaccine has gained traction over the years as the disease is preventable only through vaccination and no other specific treatments exist for it.

The major factors that fuel the growth of the market are an increase in the incidence of rubella infection globally Approximately 100,000 infants are affected by rubella annually, thus increasing the government focus on rubella vaccination, which further propels the market growth. However, inherent disadvantages of using human diploid cell technology for constructing rubella vaccines such as high selectivity and insufficient yield, restrain the growth of the market. Conversely, ongoing R&D activities for the advancement of rubella vaccines are expected to offer lucrative opportunities for the growth of the market.

The global Rubella Vaccine market is segmented on the basis of End User. On the basis of End User, the market is segmented into Pediatric Rubella Vaccine, Adult Rubella Vaccine, and Traveler Rubella Vaccine.

On the basis of geography, the Rubella Vaccine market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America accounted for the largest share of the Rubella Vaccine market followed by Europe and Asia Pacific.  Asia Pacific is expected to witness the highest CAGR in the coming years.

The market is dominated by companies like Merck & Co., Inc., GlaxoSmithKline Plc, Chiron Corporation (Novartis), Sanofi-Aventis, Serum Institute of India, Astellas Pharma Inc., AstraZeneca Plc. (Medimmune, LLC.), CSL Limited, Pfizer Inc., and Berna Biotech (Crucell).

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 End User                      

                                5.1.1 Introduction           

                                5.1.2 Pediatric Rubella Vaccine  

                                5.1.3 Adult Rubella Vaccine         

                                5.1.4 Traveler Rubella Vaccine   

                                5.1.5  Y-o-Y Growth Analysis, By End User            

                                5.1.6  Market Attractiveness Analysis, By End User          

                                5.1.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co. Inc.                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline Plc                

                8.3 Chiron Corporation                 

                8.4 Sanofi-Aventis                          

                8.5 Serum Institute of India                        

                8.6 Astellas Pharma Inc.                               

                8.7 AstraZeneca Plc.                       

                8.8 CSL Limited                 

                8.9 Pfizer Inc.                    

                8.10 Berna Biotech                         

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Region, by End user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Global Rubella Vaccine  Market By Region, From 2019-2024 ( USD Million )
  2. Global Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  3. Global Pediatric Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  4. Global Adult Rubella Vaccine  Market By Region, From 2019-2024 ( USD Million )
  5. Global Traveler Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  6. North America Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  7. North America Pediatric Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  8. North America Adult Rubella Vaccine  Market By Region, From 2019-2024 ( USD Million )
  9. North America Traveler Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  10. United States Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  11. Canada Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  12. Europe Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  13. Europe Pediatric Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  14. Europe Adult Rubella Vaccine  Market By Region, From 2019-2024 ( USD Million )
  15. Europe Traveler Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  16. U.K. Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  17. Germany Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  18. France Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  19. Italy Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  20. Spain Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  21. Asia Pacific Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  22. Asia Pacific Pediatric Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  23. Asia Pacific Adult Rubella Vaccine  Market By Region, From 2019-2024 ( USD Million )
  24. Asia Pacific Traveler Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  25. Japan Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  26. China Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  27. India Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  28. Australia Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  29. South Korea Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  30. Latin America Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  31. Latin America Pediatric Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  32. Latin America Adult Rubella Vaccine  Market By Region, From 2019-2024 ( USD Million )
  33. Latin America Traveler Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  34. Brazil Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  35. Argentina Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  36. Mexico Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  37. Rest of Latin America Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  38. Middle East and Africa Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  39. Middle East and Africa Pediatric Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  40. Middle East and Africa Adult Rubella Vaccine  Market By Region, From 2019-2024 ( USD Million )
  41. Middle East and Africa Traveler Rubella Vaccine Market By Region, From 2019-2024 ( USD Million )
  42. Middle East Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )
  43. Africa Rubella Vaccine  Market By End User, From 2019-2024 ( USD Million )

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients

Research Areas